Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Charles River Laboratories (CRL)

Charles River raises 2025 non-GAAP EPS guidance to $9.90-$10.30 after Q2 results

Mixed Impact 4 of 5 earnings Written later

Charles River reported second-quarter 2025 revenue of $1.03 billion, up 0.6% as reported but down 0.5% organically, and non-GAAP earnings per share of $3.12, up 11.4%. GAAP earnings per share fell to $1.06 from $1.74, mainly due to accelerated amortization and restructuring and legal costs. The company raised its full-year non-GAAP earnings per share guidance but lowered its GAAP earnings per share guidance.

Key points

  • Q2 revenue was $1,032.1 million, up 0.6% reported and down 0.5% organic; DSA segment organic revenue fell 2.4%.
  • Q2 GAAP net income available to common shareholders was $52.3 million, or $1.06 per share, versus $90.0 million, or $1.74 per diluted share, a year earlier.
  • 2025 non-GAAP EPS guidance was raised to $9.90-$10.30 from $9.30-$9.80; GAAP EPS guidance was lowered to $4.25-$4.65 from $4.35-$4.85.
  • The company said the U.S. Department of Justice had closed the grand jury and parallel civil investigations into its NHP shipments.

The filing

CompanyCharles River Laboratories (CRL)
Form8-K, current report
Filed with the SECAug 6, 2025, 7:08 AM ET
Accession number0001100682-25-000032

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:11 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.